Blue Nevus Melanoma Foundation
Nonprofit profile at a glance
- EIN
- 331267965
- IRS 990-EZ coverage
- 2025–2025
- Forms available
- Form 990-EZ 2025
- Location
- Atherton, CA, USA
- Phone
- 6507998593
- Rating
- 49
- Verdict
- MIXED
- Rating confidence
- Moderate
- Sector
- Cancer
Reported finances
- Revenue
- $122,589
- Expenses
- $41,779
- Assets
- $82,990
- Liabilities
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
3 people listed
Executive titles in this filing
- Vern Norviel (CEO)
People named in this filing
- Maya Skubatch (Secretery)
- Ariela Tannenbaum (CFO)
- Vern Norviel (CEO)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
A foundation to support research for Blue Nevus Melanoma (BNM). BNM is an ultra rare condition and an aggressive form of Melanoma cancer. There is a dire need to develop new treatments and drugs for it as the standard of care for Melanoma is not effective against Blue Nevus Melanoma.
What it reported doing in 2025
In 2025, the foundation initiated a research to develop a new drug for Blue Nevus Melanoma (BNM). the foundation supported a UCSF lab to extend their work to also study BNM. In 2025, the foundations grants Research so far supported UCSF lab to collaborate with an external company to screen a large library of 1.2 trillion molecules. The screening identified a handful of candidates that are now being evaluated for further studies as candidate for an initial future medication.
Operating model
- Revenue model
- Donor-supported. 100% of the money available for current operations came from contributions and gifts.
- Distribution model
- Cannot be determined from the filing. The filing does not provide enough consistent spending detail to tell whether the nonprofit works directly or through others.
The verdict
MIXED - The filed numbers largely add up and revenue comfortably covers expenses. A relatively small share of available resources goes toward mission work and a relatively small share of total spending goes to programs.
Rating breakdown
- Financial Efficiency: 9
- Transparency & Controls: 100
- Sustainability: 85
- Growth: NotEnoughData
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 5.4%; rating input score 5
- Program expense ratio: 15.8%; rating input score 16
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Yes; rating input score 100
Sustainability
- Operating margin: 65.9%; rating input score 96; 96th percentile among comparable filings
- Total-asset coverage ratio: 1.99; rating input score 79; 79th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 74; 74th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 63; 63rd percentile among comparable filings
Growth
- Program expense growth: Limited
- Revenue growth: Limited
- Asset growth: Limited
Details
- Where the money goes: 5.4% of revenue deployed · 15.8% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 2 filed program accomplishments · $7K in reported program spending
- Leadership: top reported pay $0 · 3 people listed
- Consistency: 8 of 9 current checks pass · 1 finding to review
- Schedules: 3 filed schedules
- Filing history: 1 filing year from 2025
- Contacts: How to reach this organization
- Money network: Resolved incoming and outgoing counterparties from filed money flows.
- Related organizations: Filed and resolved organization relationships.
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Financial Efficiency: Mission deployment rate scored 5/100.
- High — Financial Efficiency: Program expense ratio scored 16/100.
- Moderate — Transparency & Controls: Part III transfer expenses within program total did not reconcile in the filed values.